APA (7th ed.) Citation

G, S. K., K, S., T, M., V, C. Š., U, K., M, P., & J, R. B. (2026). Impact of elexacaftor/tezacaftor/ivacaftor on the presence of bacterial and fungal pathogens in the lower respiratory tract of children with cystic fibrosis. Respiratory medicine, 257, 108846. https://doi.org/10.1016/j.rmed.2026.108846

Chicago Style (17th ed.) Citation

G, Setnikar Kimovec, Seme K, Matos T, Cvitković Špik V, Krivec U, Praprotnik M, and Rodman Berlot J. "Impact of Elexacaftor/tezacaftor/ivacaftor on the Presence of Bacterial and Fungal Pathogens in the Lower Respiratory Tract of Children with Cystic Fibrosis." Respiratory Medicine 257 (2026): 108846. https://doi.org/10.1016/j.rmed.2026.108846.

MLA (9th ed.) Citation

G, Setnikar Kimovec, et al. "Impact of Elexacaftor/tezacaftor/ivacaftor on the Presence of Bacterial and Fungal Pathogens in the Lower Respiratory Tract of Children with Cystic Fibrosis." Respiratory Medicine, vol. 257, 2026, p. 108846, https://doi.org/10.1016/j.rmed.2026.108846.